13F filer · CIK 1792206
Foresite Capital Management V, LLC
WEST HOLLYWOOD, CA · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$362.2M
+$91.2M vs prior
Positions
9
New / sold out
1 / 1
Added / reduced
2 / 1
Turnover
0.2%
buys $34.9M · sells $783.0K
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | Pharvaris N.V. | +470,017 | +242.1% | +$16.3M |
| New | Odyssey Therapeutics, Inc. | +713,105 | – | +$13.3M |
| Added | CG Oncology, Inc. | +75,000 | +7.5% | +$5.3M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | Maze Therapeutics, Inc. | -25,905 | -100.0% | $-773.3K |
| Reduced | Lyell Immunopharma, Inc. | -692 | -0.1% | $-9.7K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ALUMIS INC.COM | 5,896,995 | $165.9M | 45.81% |
| 2 | CG Oncology, Inc.COM | 1,079,050 | $76.7M | 21.17% |
| 3 | Disc Medicine, Inc.COM | 374,069 | $27.4M | 7.55% |
| 4 | Hims & Hers Health, Inc.COM CL A | 738,151 | $25.6M | 7.07% |
| 5 | Pharvaris N.V.COM | 664,142 | $23.0M | 6.34% |
| 6 | Eikon Therapeutics, Inc.COM | 1,318,983 | $17.2M | 4.75% |
| 7 | Odyssey Therapeutics, Inc.COM | 713,105 | $13.3M | 3.68% |
| 8 | Lyell Immunopharma, Inc.COM | 476,386 | $6.7M | 1.85% |
| 9 | Nurix Therapeutics, Inc.COM | 265,000 | $6.4M | 1.77% |